NewsMeter
$5.16 million in aggregate principal amount is the corrected figure at the center of Tenon Medical, Inc.'s (Nasdaq: TNON) amended Form 8-K/A, filed August 26, 2026, which restates a March 17, 2026 original report that had listed the principal erroneously at $4.3 million.
The Los Gatos, California company simultaneously reset the conversion floor price in an amended exhibit to $0.1567 per share.
Gross proceeds from the March 11, 2026 private placement remain approximately $4.3 million before placement agent fees, reflecting the 20% original issue discount built into the notes' face amount.
The distinction is load-bearing. At maturity, noteholders hold $5.16 million in face claims, not the $4.3 million of cash they advanced.
Keep reading